Role of atrial natriuretic factor, cyclic GMP and the renin-aldosterone system in acute volume regulation of healthy human subjects

Eur J Clin Invest. 1988 Aug;18(4):425-9. doi: 10.1111/j.1365-2362.1988.tb01035.x.

Abstract

The role of the atrial natriuretic factor (ANF), its second messenger cyclic guanosine monophosphate (cGMP), and the counteracting renin-aldosterone system in acute volume regulation was investigated in 25 healthy human subjects. Central volume stimulation by 1-h head-out water immersion (WI) into a thermoneutral water-bath increased plasma levels of ANF (mean +/- SEM) from 6.0 +/- 0.6 to 13.6 +/- 2.6 fmol ml-1. This was paralleled by a rise of plasma cGMP levels from 1.9 +/- 0.2 to 2.8 +/- 0.4 pmol ml-1, and an increase of urinary cGMP excretion from 340 +/- 64 to 692 +/- 103 pmol min-1. Water immersion reduced plasma aldosterone concentration (PAC) from 13.0 +/- 1.7 to 6.5 +/- 0.8 ng 100 ml-1 and plasma renin activity (PRA) from 5.3 +/- 0.9 to 2.4 +/- 0.3 ng AI ml-1 h-1. Volume stimulation markedly increased diuresis and natriuresis. Whereas the plasma cGMP increase correlated with plasma ANF stimulation, neither ANF nor PRA or PAC correlated with basal or stimulated renal parameters. Water immersion-induced changes in natriuresis and urinary cGMP excretion were correlated. These data suggest a role of ANF and cGMP in acute volume regulation of healthy human subjects.

MeSH terms

  • Adult
  • Aged
  • Atrial Natriuretic Factor / blood
  • Atrial Natriuretic Factor / physiology*
  • Cyclic GMP / blood
  • Cyclic GMP / physiology*
  • Extracellular Space / physiology*
  • Female
  • Humans
  • Immersion
  • Male
  • Middle Aged
  • Natriuresis
  • Renin-Angiotensin System*
  • Water

Substances

  • NPPA protein, human
  • Water
  • Atrial Natriuretic Factor
  • Cyclic GMP